ArticlePloS one2012

Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.

Nelson Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.